Faecal “bacterial gene markers” test (M3) was developed by the Faculty of Medicine at The Chinese University of Hong Kong.

Clearbridge Medical M3CRC Gut Health Screening (NON-INVASIVE colorectal cancer risk prediction test)

• M3CRC is the world's only non-invasive colorectal cancer risk prediction test that defects non-advanced adenoma, which is designed for people who have concerns about gut health. The Programme adopts the world’s first faecal “bacterial gene markers” test (M3)* developed by the Faculty of Medicine at The Chinese University of Hong Kong. This non-invasive test can detect colorectal cancer (CRC) early and can also be applied to the prediction of polyp recurrence.*
• Easy and convenient: only stool sample is required, 94% sensitivity for CRC
• Sensitivity for adenoma superior to currently available non-invasive tests
• Tailored for Asians
• Doctors to conduct health consultation & Physical examination
• Medical result report interpretation by doctor
• Medical report attaches dietary recommendations